Results 91 to 100 of about 40,091 (215)

Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment

Advanced Science, Volume 13, Issue 10, 18 February 2026.
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang, Siqi Mu, Juan Zhang, Guisong Shan, Xueqian Li, Ran Wang, Tao Guo, Xiaoyan He   +7 more
wiley   +1 more source

Facilitators and barriers for use of rotavirus vaccine amongst various stakeholders and its implications for Indian context – A systematic review

Human Vaccines & Immunotherapeutics, 2018
Background: We performed a systematic review to evaluate factors affecting uptake of rotavirus vaccine amongst physicians, parents and health system. Methods: We identified 15 studies that met the inclusion criteria from 790 screened studies published ...
Aditi Apte, Sudipto Roy, Ashish Bavdekar, Sanjay Juvekar, Siddhivinayak Hirve   +4 more
doaj   +1 more source

Impact of rotavirus vaccination on child mortality, morbidity, and rotavirus-related hospitalizations in Bolivia

International Journal of Infectious Diseases, 2017
Background: The public health impact of rotavirus vaccination in countries with high child mortality rates remains to be established. The RV1 rotavirus vaccine was introduced in Bolivia in August 2008.
Lucia Inchauste, Maritza Patzi, Kjetil Halvorsen, Susana Solano, Raul Montesano, Volga Iñiguez   +5 more
doaj   +1 more source

Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation. [PDF]

, 2012
In pediatric patients with malignancy and those receiving hematopoietic stem cell transplants, bacterial and fungal infections have been the focus of fever and neutropenia episodes for decades.
Alexander, Sarah, Dvorak, Christopher C, Fisher, Brian T, Sung, Lillian, Zaoutis, Theoklis E, Zerr, Danielle M   +5 more
core   +1 more source

Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa

Expert Review of Vaccines, 2017
Introduction: Rotavirus is the leading cause of hospitalizations and deaths from diarrhea. 33 African countries had introduced rotavirus vaccines by 2016.
Minesh P. Shah, Jacqueline E. Tate, Jason M. Mwenda, A. Duncan Steele, Umesh D. Parashar   +4 more
doaj   +1 more source

Comparison of serum immunoglobulin G half-life in dairy calves fed colostrum, colostrum replacer or administered with intravenous bovine plasma. [PDF]

, 2014
In calves, passive immunity of immunoglobulins can be acquired through ingestion of colostrum or colostrum replacers. Plasma can been used to supplement immunoglobulins in healthy or sick calves.
Chigerwe, Munashe, Hagey, Jill V, Murphy, Jacob M   +2 more
core   +1 more source

Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.

PLoS Medicine, 2019
BackgroundDespite the success of rotavirus vaccines over the last decade, rotavirus remains a leading cause of severe diarrheal disease among young children.
Julia M Baker, Jacqueline E Tate, Juan Leon, Michael J Haber, Benjamin A Lopman   +4 more
doaj   +1 more source

Rotavirus Burden, Genetic Diversity and Impact of Vaccine in Children under Five in Tanzania

Pathogens, 2019
In Tanzania, rotavirus infections are responsible for 72% of diarrhea deaths in children under five. The Rotarix vaccine was introduced in early 2013 to mitigate rotavirus infections.
Joseph J. Malakalinga, Gerald Misinzo, George M. Msalya, Rudovick R. Kazwala   +3 more
doaj   +1 more source

Antigenic and biochemical characterization of bovine rotavirus V1005, a new member of rotavirus serotype 10 [PDF]

, 1990
Bovine rotavirus (BRV) V1005 is serologically distinct from rotavirus serotypes 1, 2, 3, 4, 5, 6, 8 and 9. BRV V1005 showed cross-reactions with BRV B223, the American prototype of serotype 10 rotavirus, and with BRV E4049, a British serotype 10 isolate.
Bruttin, Anne, Büssow, Harald, Eichhorn, Werner, Fitzgerald, Tracey, Gerhards, Roswitha, Snodgrass, David   +5 more
core   +1 more source

Novel Universal Recombinant Rotavirus A Vaccine Candidate: Evaluation of Immunological Properties

Viruses
Rotavirus infection is a leading cause of severe dehydrating gastroenteritis in children under 5 years of age. Although rotavirus-associated mortality has decreased considerably because of the introduction of the worldwide rotavirus vaccination, the ...
Dmitriy L. Granovskiy, Nelli S. Khudainazarova, Ekaterina A. Evtushenko, Ekaterina M. Ryabchevskaya, Olga A. Kondakova, Marina V. Arkhipenko, Marina V. Kovrizhko, Elena P. Kolpakova, Tatyana I. Tverdokhlebova, Nikolai A. Nikitin, Olga V. Karpova   +10 more
doaj   +1 more source